Investor takeaway: Centene stock faces a challenging outlook driven by ACA pressures, higher healthcare costs, and the policy risk posed by the scheduled end of enhanced federal subsidies after 2025.
For this story, Fortune used generative AI to help with an initial draft. An editor verified the accuracy of the information before publishing.
